Tilaknagar Industries Q1 FY27 Results: July 2026 dates

Key event investors are tracking

Tilaknagar Industries Limited has scheduled a board meeting on July 27, 2026 to consider and approve its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). The update matters because it sets the formal timeline for the company’s first-quarter disclosure in FY27. It also comes at a time when the company is highlighting record monthly volumes and progress on integration-related costs. Alongside the board meeting, a post-results earnings conference call is scheduled for July 28, 2026 at 11:30 AM IST, as per the company communication shared in the provided text. The call is expected to be closely watched for commentary on margins, TSMA costs, and the deleveraging path.

Board meeting and results window

The board of directors is set to meet on Monday, July 27, 2026, to review and approve both standalone and consolidated financial results for the quarter ended June 30, 2026. This board meeting is the immediate anchor for Q1 FY27 performance reporting in the material provided. Separately, the “results date” is also referenced as July 27, 2026 in the quick details section. The same source set also uses a broader “July-August 2026” window as an indicative results period in an estimates table, consistent with the wider results season timeline for the quarter ending June 2026. Taken together, the actionable date in the company’s schedule is the July 27 board meeting.

Earnings call schedule and attendees

Tilaknagar Industries has also scheduled a post-results earnings conference call for analysts and investors on Tuesday, July 28, 2026 at 11:30 AM IST to discuss Q1 FY27 results. The invite note states the schedule is subject to change due to exigencies on the part of analysts, investors, or the company. Senior management expected to participate includes Amit Dahanukar (Chairman and Managing Director), Ameya Deshpande (Chief Strategy Officer), Rajesh Choudhary (Chief Financial Officer) and Sanaya Dahanukar (General Manager, Growth and Innovation). The call structure outlined includes brief management remarks followed by an interactive Q and A.

Volume momentum heading into Q1 FY27

The company enters Q1 FY27 with volume momentum highlighted in the provided text. Tilaknagar Industries reported record sales of 3.4 million cases in June 2026, described as its highest-ever monthly sales volume. The update also notes the company sold over 3 million cases in May 2026. These datapoints frame expectations for a strong start to FY27 from an operating perspective, and they are likely to influence how investors interpret any changes in margins or costs during the quarter.

TSMA exit and the cost run-rate focus

A key topic flagged ahead of results is the Transition Services and Manufacturing Agreement (TSMA) linked to the Imperial Blue business. As of the start of Q1 FY27, Tilaknagar Industries has exited the TSMA for approximately 75% of the Imperial Blue business, according to the text provided. The upcoming discussion is expected to focus on the TSMA expense run-rate, stated at about INR 14 crore per month in Q4 FY26. For investors, the near-term question is how quickly these transitional expenses normalise as the company moves further away from the TSMA phase.

Deleveraging path and net debt target

The company’s net debt is another central monitorable item in the run-up to Q1 results. The quick details section lists net debt (latest quarter) at INR 1,934 crore. The company has a stated net debt target of INR 1,700 crore by March 2027, which implies investors will watch Q1 movement against the INR 1,934 crore base. The narrative in the source also frames deleveraging as an explicit area of interest on the upcoming call, alongside the TSMA cost line.

Guidance markers and what “better” looks like

The provided text lists operational markers that investors are expected to track through FY27 and beyond. Combined business volume growth is described as “high-single digit to low-double digit for FY27,” with Q1 FY27 being the first tracking period. On profitability, combined business EBITDA margin is referenced at 16% to 18% by FY29, with a note to watch for sequential improvement from a 15.5% adjusted margin in Q4 FY26. The quick details section also lists the previous quarter EBITDA margin at 16.3%, underscoring that headline and adjusted margin narratives may differ based on how transition costs are treated.

Street-style estimates and valuation snapshots in the source

The material also includes an estimates range for Q1 FY27 that is explicitly presented as an external framework. It lists Q1 FY27E revenue at INR 1,211 to 1,393 crore and PAT at INR 39 to 50 crore, while citing a Q1 FY26 base of INR 868 crore revenue and INR 89 crore net profit used in the estimate logic. The same set of text references a 12-month target price range of INR 546 to 605. It also includes a valuation datapoint that the stock was trading at INR 455 with a market capitalisation of about INR 11,243 crore and a price-to-earnings multiple of 540.8 (as stated). These are not company projections, but they shape the expectations environment around the board meeting and call.

Market snapshot and key data points

Trading and market-cap figures in the provided text vary by snapshot, suggesting they were captured at different times. One quick-details block lists CMP at INR 441.25 and market cap at INR 10,919.77 crore. Another block references shares trading at INR 455 and market cap of about INR 11,243 crore. A separate line shows “Today: 430.35” without additional context. For readers, the more durable takeaway is the event schedule and the operational and balance-sheet items likely to be discussed, rather than the exact intraday price.

Summary table: dates, financial base, and watch items

Why this results print matters

The July 27 board meeting is important because it is the first Q1 reporting checkpoint after the company highlighted record monthly volumes in May and June 2026. If volume momentum remains strong, investor attention may shift to how much of the upside is retained in margins after accounting for transition and legal costs referenced in the broader text. The TSMA run-rate and the pace of TSMA exit are directly linked to near-term cost optics, particularly if the company previously carried around INR 14 crore per month in Q4 FY26 on that line. And with net debt cited at INR 1,934 crore and a March 2027 target of INR 1,700 crore, Q1 balance-sheet movement becomes a measurable indicator rather than a qualitative narrative.

Conclusion

Tilaknagar Industries’ Q1 FY27 results calendar is centred on the July 27, 2026 board meeting, followed by a scheduled earnings call on July 28, 2026 at 11:30 AM IST. The company’s recent disclosures point to strong volume momentum, ongoing TSMA unwind, and an explicit net-debt reduction goal through March 2027. Investors will look to the Q1 FY27 release and management commentary for clarity on transition cost normalisation, margin trajectory, and progress toward deleveraging targets.